Ashfield Capital Partners, LLC Abb Vie Inc. Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 77,250 shares of ABBV stock, worth $14.1 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

77,250

Previous 77,160 0.12%

Holding current value

$14.1 Million

Previous $11.8 Million 12.27%

% of portfolio

0.87%

Previous 0.92%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $12,078 - $13,853	90 Added 0.12%	77,250 $10.4 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $73,901 - $93,953	-537 Reduced 0.69%	77,160 $11.8 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $31,939 - $39,627	242 Added 0.31%	77,697 $12.6 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $2.02 Million - $2.56 Million	-18,831 Reduced 19.56%	77,455 $10.5 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $194,073 - $220,302	-1,824 Reduced 1.86%	96,286 $10.4 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $736 - $820	-7 Reduced 0.01%	98,110 $11.1 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $91,865 - $101,132	898 Added 0.92%	98,117 $10.6 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $173,053 - $233,640	2,150 Added 2.26%	97,219 $10.4 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $131,614 - $154,471	-1,532 Reduced 1.59%	95,069 $8.33 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $42,774 - $57,238	583 Added 0.61%	96,601 $9.48 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $91,138 - $138,177	1,413 Added 1.49%	96,018 $7.32 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $290,178 - $363,075	-4,023 Reduced 4.08%	94,605 $8.38 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $270,247 - $324,914	-4,291 Reduced 4.17%	98,628 $7.47 Million
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $441,766 - $564,681	-6,724 Reduced 6.13%	102,919 $7.48 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $532,188 - $626,360	-6,899 Reduced 5.92%	109,643 $8.84 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $19,228 - $23,714	-247 Reduced 0.21%	116,542 $10.7 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $396,271 - $440,529	4,457 Added 3.97%	116,789 $11 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $83,585 - $98,900	931 Added 0.84%	112,332 $10.4 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $64,130 - $85,877	-697 Reduced 0.62%	111,401 $10.5 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $75,230 - $82,496	-840 Reduced 0.74%	112,098 $10.8 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $13,341 - $17,041	-191 Reduced 0.17%	112,938 $10 Million
Q2 2017 Aug 14, 2017	BUY	N/A	113,129	113,129 $8.2 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Abb Vie Inc. Transaction History